Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: A population-based cohort study

JAMA Surgery

Volumn 148, Issue 8, 2013, Pages 715-722

  Winner, Megan ^a,b   Mooney, Stephen J ^b   Hershman, Dawn L ^a,b   Feingold, Daniel L ^a   Allendorf, John D ^a   Wright, Jason D ^a   Neugut, Alfred I ^a,b  

^a Columbia University ^*  (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; COLON CANCER; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; INCIDENCE; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INTESTINAL OBSTRUCTION; MALE; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84882953233     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.1     Document Type: Article

References (49)

1. Murphy S, Xu JQ, Kochanek KD, eds. Deaths: Preliminary Data for 2010. Hyattsville, MD: National Center for Health Statistics; 2012. National Vital Statistics Report, Vol 6, No. 4.
2. DeBernardo R. Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer. Curr Oncol Rep. 2009;11(4):287-292.
3. Feuer DJ, Broadley KE, Shepherd JH, Barton DP; Systematic Review Steering Committee. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol. 1999;75(3):313-322.
4. Ketcham AS, Hoye RC, Pilch YH, Morton DL. Delayed intestinal obstruction following treatment for cancer. Cancer. 1970;25(2):406-410.
5. Ripamonti C, Mercadante S. How to use octreotide for malignant bowel obstruction. J Support Oncol. 2004;2(4):357-364. (Pubitemid 39409784)
6. Welch JP, Donaldson GA. Management of severe obstruction of the large bowel due to malignant disease. Am J Surg. 1974;127(4):492-499.
7. Ripamonti C. Management of bowel obstruction in advanced cancer. Curr Opin Oncol. 1994;6(4):351-357. (Pubitemid 24213572)
8. Roeland E, von Gunten CF. Current concepts in malignant bowel obstruction management. Curr Oncol Rep. 2009;11(4):298-303.
9. Woolfson RG, Jennings K, Whalen GF. Management of bowel obstruction in patients with abdominal cancer. Arch Surg. 1997;132(10):1093-1097. (Pubitemid 27433273)
10. Wright FC, Chakraborty A, Helyer L, Moravan V, Selby D. Predictors of survival in patients with non-curative stage IV cancer and malignant bowel obstruction. J Surg Oncol. 2010;101(5):425-429.
11. Davis MP, Nouneh C. Modern management of cancer-related intestinal obstruction. Curr Pain Headache Rep. 2001;5(3):257-264.
12. Phillips RK, Hittinger R, Fry JS, Fielding LP. Malignant large bowel obstruction. Br J Surg. 1985;72(4):296-302. (Pubitemid 15090961)
13. Ripamonti C. Management of bowel obstruction in advanced cancer patients. J Pain SymptomManage. 1994;9(3):193-200. (Pubitemid 24134452)
14. Fielding LP,Wells BW. Survival after primary and after staged resection for large bowel obstruction caused by cancer. Br J Surg. 1974;61(1):16-18.
15. Floyd CE, Cohn I Jr. Obstruction in cancer of the colon. Ann Surg. 1967;165(5):721-731.
16. Goligher JC, Smiddy FG. The treatment of acute obstruction or perforation with carcinoma of the colon and rectum. Br J Surg. 1957;45(191):270-274.
17. Irvin TT, Greaney MG. The treatment of colonic cancer presenting with intestinal obstruction. Br J Surg. 1977;64(10):741-744. (Pubitemid 8209652)
18. Sanfelippo PM, Beahrs OH. Factors in the prognosis of adenocarcinoma of the colon and rectum. Arch Surg. 1972;104(4):401-406.
19. Umpleby HC, Williamson RC. Survival in acute obstructing colorectal carcinoma. Dis Colon Rectum. 1984;27(5):299-304. (Pubitemid 14138788)
20. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748.
21. Surveillance, Epidemiology, and End Results; National Cancer Institute. Number of persons by race and Hispanic ethnicity for SEER participants, 2000 census data. 2012. http://seer.cancer.gov/registries/data.html. Accessed March 28, 2012.
22. Fritz A, Jack A, Parkin DM, et al, eds. International Classification of Diseases for Oncology, Third Edition. Geneva, Switzerland:World Health Organization; 2001.
23. Annest LS, Jolly PC. The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis. Am Surg. 1979;45(11):718-721. (Pubitemid 10214887)
24. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(8)(suppl):IV-55-IV-61.
25. Klabunde CN, Potosky AL, Legler JM,Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267. (Pubitemid 32007842)
26. Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R. Predictors of proximal vs distal colorectal cancers. Dis Colon Rectum. 2001;44(2):251-258. (Pubitemid 32173775)
27. Saltzstein SL, Behling CA. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol. 2007;41(2):173-177. (Pubitemid 46148659)
28. Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23(3):418-423. (Pubitemid 351342058)
29. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113(10):779- 788. (Pubitemid 20369667)
30. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer. 2002;101(5):403-408.
31. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors? Dig Dis. 1997;15(4-5):302-311. (Pubitemid 127522070)
32. Chee KG, Nguyen DV, Brown M, Gandara DR, Wun T, Lara PN Jr. Positron emission tomography and improved survival in patients with lung cancer: theWill Rogers phenomenon revisited. Arch Intern Med. 2008;168(14):1541-1549.
33. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244-256.
34. Aldridge MC, Phillips RK, Hittinger R, Fry JS, Fielding LP. Influence of tumour site on presentation, management and subsequent outcome in large bowel cancer. Br J Surg. 1986;73(8):663-670. (Pubitemid 16039373)
35. Ripamonti C, Twycross R, BainesM, et al Working Group of the European Association for Palliative Care. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001;9(4):223-233. (Pubitemid 32537280)
36. Helyer LK, Law CH, ButlerM, Last LD, Smith AJ, Wright FC. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Oncol. 2007;14(4):1264-1271. (Pubitemid 46536827)
37. Butler JA, Cameron BL, MorrowM, Kahng K, TomJ. Small bowel obstruction in patients with a prior history of cancer. Am J Surg. 1991;162(6):624-628.
38. Osteen RT, Guyton S, Steele G Jr, Wilson RE. Malignant intestinal obstruction. Surgery. 1980;87(6):611-615. (Pubitemid 10124238)
39. Frager D, Medwid SW, Baer JW, et al. CT of small-bowel obstruction: value in establishing the diagnosis and determining the degree and cause. AJR AmJ Roentgenol. 1994;162(1):37-41. (Pubitemid 24043670)
40. Taourel PG, Fabre JM, Pradel JA, Seneterre EJ, Megibow AJ, Bruel JM. Value of CT in the diagnosis and management of patients with suspected acute small-bowel obstruction. AJR AmJ Roentgenol. 1995;165(5):1187-1192.
41. Megibow AJ, Balthazar EJ, Cho KC, Medwid SW, Birnbaum BA, Noz ME. Bowel obstruction: evaluation with CT. Radiology. 1991;180(2):313-318.
42. Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA. The utility of Medicare claims data for measuring cancer stage. Med Care. 1999;37(7):706-711.
43. Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003;52(4):568-573. (Pubitemid 36363413)
44. Scoggins CR,Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6(7):651-657.
45. Scheer MGW, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol. 2008;19(11):1829-1835.
46. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27(20):3379-3384.
47. Ballian N, Mahvi DM, Kennedy GD. Colonoscopic findings and tumor site do not predict bowel obstruction during medical treatment of stage IV colorectal cancer. Oncologist. 2009;14(6):580-585.
48. Nitzkorski JR, Farma JM,Watson JC, et al. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection. Ann Surg Oncol. 2012;19(2):379-383.
49. Winner M, Mooney SJ, Hershman DL, et al. Management and outcomes of bowel obstruction in stage IV colon cancer patients: a population-based cohort study. Dis Colon Rectum. In press.